Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.380
+0.010 (0.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Compass Therapeutics Employees
Compass Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$26,563
Profits / Employee
-$1,492,406
Market Cap
189.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amarin Corporation | 275 |
| Fate Therapeutics | 181 |
| Molecular Partners AG | 168 |
| Gossamer Bio | 135 |
| Stereotaxis | 122 |
| Perspective Therapeutics | 119 |
| Myomo | 106 |
| MediWound | 100 |
CMPX News
- 11 days ago - Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - GlobeNewsWire
- 12 days ago - Compass Therapeutics: Near-Term Readout, But Beware The High Stakes In Biliary Cancer - Seeking Alpha
- 19 days ago - Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Compass Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 5 weeks ago - Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 2 months ago - Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 4 months ago - Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference - GlobeNewsWire